Study: Statins may protect hep C patients from liver cancer

03/22/2013 | Reuters

The use of cholesterol-lowering statin drugs among patients with chronic hepatitis C was associated with a decreased risk of liver cancer, according to a study of around 261,000 patients in Taiwan. The reductions were modest, but the findings could address possible concerns about prescribing statins to patients with liver disease, a U.S. researcher commented. The study appeared in the Journal of Clinical Oncology.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX